Related Experiment Videos
Adrenoceptor genes in human obesity.
1Department of Medicine, Huddinge Hospital, Karolinska Institute, Stockholm, Sweden. peter.arner@medhs.ki.se
Journal of Internal Medicine
|July 8, 1999
Summary
Genetic variations in beta-adrenergic receptor genes are linked to human obesity. Specific polymorphisms in beta3 and beta2 receptors show associations with increased obesity risk and fat mass.
Area of Science:
- Genetics
- Metabolism
- Endocrinology
Background:
- Rodent obesity genes are not key in human obesity.
- Beta-adrenergic receptors regulate energy utilization.
- Polymorphisms in beta-adrenergic receptor genes are studied for obesity links.
Purpose of the Study:
- Investigate the association between beta-adrenergic receptor gene polymorphisms and human obesity.
- Understand the functional impact of these genetic variants on receptor activity and obesity risk.
Main Methods:
- Analysis of beta3-adrenergic receptor (Trp64Arg) and beta2-adrenergic receptor (Gln27Glu) gene polymorphisms.
- Functional studies of receptor variants in cell systems and human fat cells.
- Epidemiological assessment of relative risk and odds ratios for obesity associated with polymorphisms.
Main Results:
- Beta3-adrenergic receptor polymorphism (Trp64Arg) shows a moderate association with obesity in some populations.
- Beta2-adrenergic receptor polymorphism (Gln27Glu) is strongly associated with obesity in women, increasing relative risk and fat mass.
- Functional studies confirm altered receptor activity due to these polymorphisms.
Conclusions:
- Polymorphisms in beta-adrenergic receptor genes (beta2 and beta3) are significant factors in the development of human obesity.
- Genetic variations in these receptors influence energy metabolism and contribute to obesity risk.
- Further research into adrenergic receptor genetics is warranted for understanding and treating obesity.